Need to keep on high of the science and politics driving biotech in the present day? Enroll to get our biotech publication in your inbox.
Hello, it’s Meghana. Right now, Illumina lastly finds an advocate within the EU, a CRISPRed pig kidney is transplanted right into a residing human, and extra.
Is there a remedy for allergic reactions?
Has the FDA develop into too versatile? And which medication make you muscular? We cowl all that and extra this week on “The Readout LOUD,” STAT’s biotech podcast.
Recorded stay from the STAT Breakthrough Summit East in New York Metropolis, we talk about some occasion highlights, together with phrases from CRISPR pioneer Feng Zhang and Regeneron Prescription drugs head scientist George Yancopoulos. We additionally talk about the newest information within the life sciences, together with a twist within the GLP-1 story, the price of gene remedy, and, after all, pie.
Hear right here.
EU adviser says Illumina merger was not problematic
Lastly, a win for Illumina — for whom it’s been doom and gloom for fairly a while, after an $8 billion effort to accumulate Grail was blocked by European regulators. Now, Nicholas Emiliou, advocate normal of the Court docket of Justice of the EU, has stated that call was improper and should be reversed, Financial Times writes. Though this isn’t a legally binding resolution, these choices are usually adopted by the EU’s highest court docket, which is able to seemingly rule on Illumina’s case later this 12 months.
The EU’s 2022 resolution to dam Illumina’s acquisition of Grail was thought-about controversial as a result of Grail had no income or presence in Europe.
“Illumina agrees with the Advocate Normal that the European Fee’s assertion of jurisdiction over this merger was improper,” the corporate stated in an e-mail to Reuters.
Ought to orphan medication be exempt from value caps?
Some drugmakers are lobbying for orphan medication to be exempt from the value caps being set by state boards. Some lawmakers are backing these efforts, citing concern that sufferers would possibly lose entry to such medication if pharmaceutical corporations resolve to cease promoting or investing in them.
Nevertheless, opponents argue that these exceptions may find yourself getting used for blockbuster medication which can be additionally used to deal with orphan ailments. Client advocates consider that value cap laws would in the end make it tougher for sufferers to pay for his or her remedy — in the end preserving income for drugmakers.
“I do know of us who’ve these uncommon ailments. They’re scared. They’re harassed. They’re involved if [the price of a drug] does get capped they might not get their drugs,” one state senator who used to work in massive pharmaceutical corporations instructed STAT. “I don’t wish to take that probability with this group of individuals. I don’t know whether or not corporations would pull out or not however is it value taking that probability?”
Learn extra.
Pig kidney transplanted into residing human
Surgeons have transplanted the primary kidney from a CRISPR gene-edited pig right into a residing human affected person. Richard Slayman, a 62-year-old man who had beforehand acquired a human kidney transplant, underwent the landmark xenotransplantation process final Saturday at Massachusetts Normal Hospital. As of Thursday morning, he was up and strolling.
The porcine kidney was engineered by eGenesis, a Massachusetts biotech that’s creating a wide range of human-compatible pig organs utilizing CRISPR know-how.
“We hope to be taught if the sturdy transplant outcomes that we noticed in non-human primates, revealed in Nature in October, translate in to sufferers,” eGenesis CEO Mike Curtis instructed STAT. “How effectively the affected person and the graft do can be useful info and inform the design of future research.”
Learn extra.
Extra reads
- Wegovy to be lined by Medicare for coronary heart illness sufferers, Reuters
- Canine longevity startup Loyal secures $45 million financing, Wall Street Journal
- Ibogaine, the psychedelic, unlikely to obtain approval as opioid remedy, says high habit researcher, STAT
- J&J’s Abided sees severe Impella recall linked to coronary heart perforations, 49 deaths, FierceBiotech
